Latest Asx Compliance News

Trading in Alliance Aviation Services Limited (AQZ) shares has resumed following the lifting of a suspension tied to a recent trading update announcement.

Finexia Financial Group Limited (ASX – FNX) has had its trading suspension lifted immediately following its public response to recent media speculation. The reinstatement marks a pivotal moment for the financial group’s market activity.

ALS Limited has responded to an ASX inquiry regarding the delayed lodgement of key disclosure documents related to performance rights granted to director Malcolm Deane, attributing the delay to human error and outlining steps to reinforce compliance.

Mont Royal Resources Limited will have its trading suspension lifted and resume quotation on the ASX from 5 November 2025 following regulatory compliance.

Bentley Capital Limited has voluntarily suspended trading of its shares on the ASX pending a market announcement addressing a recent price and volume query. The suspension is expected to last until early November, signaling heightened regulatory scrutiny.

NT Minerals Limited reported a net cash outflow of A$590,000 for Q3 2025 but bolstered its liquidity with A$1.07 million from investing activities, leaving it with over two quarters of funding runway.

Polymetals Resources Ltd has had its trading suspension lifted following an announcement about a serious safety incident at its Endeavor Mine Site, raising questions about operational impacts and regulatory responses.

BauMart Holdings reports progress in AI-driven international recruitment and sustainable building materials development, alongside a $180,000 capital raise to support growth initiatives.

Pantera Lithium Limited has had its ASX trading suspension lifted following the release of a significant announcement on material tenement agreements, signaling renewed market activity.

Stavely Minerals Limited reported a net cash outflow from operations of AUD 1.264 million for Q3 2025 but bolstered its cash reserves through financing activities, ending the quarter with AUD 1.722 million. The company signals a strategic reduction in exploration expenditure for the upcoming quarter to sustain operations.

OncoSil Medical Limited has addressed ASX concerns over delayed disclosure of PANCOSIL clinical trial results, confirming compliance with continuous disclosure obligations despite procedural oversights.

Freehill Mining Limited has addressed an ASX query over the late filing of a director’s interest notice, attributing the delay to an administrative oversight and reaffirming its compliance protocols.